MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    PPP2R5D Variants in Patients Diagnosed With Parkinson’s Disease. A Large‑Scale Multi‑Cohort Analysis

    I. Keller Sarmiento, R. Bovenzi, V. Quintana, G. Cogan, A. Brice, A. Gajos, M. Bozi, L. Lange, G. Benbir Senel, B. Tserensodnom, H. Kim, M. Marti, A. Dilliott, H. Morris, S. Lim, A. Tan, R. Alcalay, J. Trinh, C. Klein, N. Mencacci (Chicago, USA)

    Objective: To identify individuals with rare pathogenic and potentially pathogenic variants of unknown significance (VUS) in PPP2R5D within large Parkinson’s disease (PD) cohorts, to characterize…
  • 2026 International Congress

    Spatiotemporal Biomarkers of Early Postural Instability in Parkinson’s Disease: Implications for Early Intervention

    R. Taniuchi, T. Harada, T. Torii, H. Kowa (Matsue, Japan)

    Objective: To characterize spatiotemporal biomarkers derived from a quantitatively assessed pull test in patients with early Parkinson’s disease (PD). Background: The pull test is a…
  • 2026 International Congress

    Smell as a Diagnostic Signature: Systematic Review and Meta-Analysis of UPSIT Accuracy in Distinguishing Parkinson’s Disease from Essential Tremor

    M. Schiess, J. Martinez-Lemus, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)

    Objective: To evaluate the diagnostic performance of the University of Pennsylvania Smell Identification Test (UPSIT) in differentiating Parkinson’s disease (PD) from essential tremor (ET) using…
  • 2026 International Congress

    Effects of Modafinil on Motor and Non‑Motor Outcomes in Parkinson’s Disease: A Meta‑Analysis of Randomized, Placebo‑Controlled Trials

    A. Lin, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Cincinnati, USA)

    Objective: To determine the efficacy and safety of modafinil on motor and non-motor outcomes in Parkinson’s disease (PD) using evidence exclusively from randomized placebo‑controlled clinical…
  • 2026 International Congress

    Evaluating the Stability of a Short Smell Test in the PREDICT-PD Cohort

    S. Meyer, A. Kuri, J. Bestwick, S. Waters, H. Chohan, A. Shahid, L. Smith, C. Simonet, L. Pérez-Carbonell, E. de Pablo-Fernandez, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To evaluate the stability of a 6-item smell test, in the context of a prodromal Parkinson’s (PD) cohort. Background: Short smell tests have been…
  • 2026 International Congress

    12-week Aerobic Interval Training Induces Hemisphere-Specific Neuroprotection in Parkinson’s Disease: A Multimodal MRI, [18F]Fluorodopa PET/CT and BDNF Study

    K. Lorek, B. Kossowski, A. Marchewka, M. Chalimoniuk, J. Langfort, J. Mączewska, L. Królicki, K. Markowska, S. Budrewicz, M. Koszewicz, Z. Wroński, J. Marusiak (Wroclaw, Poland)

    Objective: To investigate whether a 12-week aerobic interval training (AIT) can preserve subcortical brain structures in early Parkinson’s disease (PD) and whether these effects are…
  • 2026 International Congress

    Phenoconversion from Rapid Eye Movement Sleep Behavior Disorder to Parkinson’s Disease: A multimodal Imaging Study

    J. Ebina, K. Kamiya, M. Hori, M. Shibukawa, J. Nagasawa, T. Hirayama, S. Mizumura, O. Kano (Tokyo, Japan)

    Objective: To elucidate the pathological progression from rapid eye movement sleep behavior disorder (RBD) to Parkinson’s disease (PD), we investigated tissue-level neurodegenerative changes using multimodal…
  • 2026 International Congress

    Electrophysiological Evaluation of Visual Hallucination in Parkinson’s Disease Psychosis

    Z. Piazza, G. Schwartz (Stony Brook, USA)

    Objective: Our understanding of the psychosis in Parkinson’s disease (PDPsy) is incomplete, and standard of care treatment with antipsychotics has its limitations. Neuroimaging and histopathology in PDPsy reveal that visual hallucinations (VHs), the hallmark of psychosis in PDPsy, arise…
  • 2026 International Congress

    Parkinson’s Disease Duration at Total Knee Arthroplasty and 5-Year Vascular and Periprosthetic Outcomes: A Nationwide Matched Cohort Study

    D. Kwon, H. Park (Seoul, Republic of Korea)

    Objective: The objective of the study was to evaluate whether Parkinson's disease (PD) is associated with long-term risks of vascular events (cardiovascular and cerebrovascular) and…
  • 2026 International Congress

    Considering Oral Health to Optimise the Potential for Current and Future Treatments in Parkinson’s Disease

    J. Price, H. Martin (Powys, United Kingdom)

    Objective: To determine if the Oral Health Assessment Questionnaire (OHAQ) devised by 2 Parkinson’s Disease Nurse Advanced Practitioners (PDNAP) could facilitate a healthier mouth to…
  • « Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley